Stock Financial Ratios, Dividends, Split History

BBW / Build-A-Bear Workshop, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price7.75
Volume1,560,800.00
Market Cap ($M)131.12
Enterprise Value ($M)100.68
Book Value ($M)111.42
Book Value / Share7.42
Price / Book1.22
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding 14,900,452
Weighted Average Number Of Shares Outstanding Basic 15,572,045
Weighted Average Number Of Diluted Shares Outstanding 15,757,060
Preferred Stock Shares Outstanding 0
Common Stock Shares Outstanding 15,515,960
Scoring Models
Piotroski F-Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.07
Return on Assets (ROA)0.04
Return on Equity (ROE)0.08
Balance Sheet (mrq) ($M)
Assets172.65
Liabilities61.24
Quick Ratio0.97
Current Ratio2.19
Income Statement (mra) ($M)
Commercial Revenue6,007,000.00
Franchise Revenue2,451,000.00
Revenues357,866,000.00
Sales Revenue Goods Net349,408,000.00
Sales Revenue Net0.00
Net Income7.92
Earnings Per Share Basic0.50
Earnings Per Share Diluted0.50
Cash Flow Statement (mra) ($M)
Cash From Operations21.09
Cash from Investing-17.76
Cash from Financing-17.76
Identifiers and Descriptors
CUSIP120076104
Central Index Key (CIK)1113809
Related CUSIPS
120076954 012007610

Split History

Stock splits are used by Build-A-Bear Workshop, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

Bear of the Day: 58.com (WUBA)

2018-06-22 zacks
With threats of a trade war continuing to loom over the market you probably want to avoid going face-first into Chinese stocks right now. Eventually the selling could lead to a great opportunity, but if you are one of those contrarians, you may want to find stocks that have earnings estimates moving in a positive direction. Today’s Bear of the Day is a Chinese internet stock that’s seen its earnings estimates move to the downside. (28-0)

Bear of the Day: Build-A-Bear Workshop (BBW)

2018-06-21 zacks
Founded in 1997 and headquartered in St. Louis, MO, Build-A-Bear Workshop (BBW - Free Report) is a retailer of plush animals that provides an interactive make-your-own stuffed animal entertainment experience. (13-0)

Should You Buy Facebook (FB) Stock At New All-Time High?

2018-06-21 zacks
Facebook (FB - Free Report) stock climbed over 2.2% on Wednesday to touch a new all-time high after the company announced that its Instagram platform rolled out a new long-form video feature in a move that will see it compete more directly against the likes of Google’s (GOOGL - Free Report) YouTube. Cleary, it didn’t take many investors too long to move on from Facebook’s data scandal woes. But let’s take some time to see if Facebook stock seems like a buy at the moment. (147-0)

Use DuPont Analysis to Pick 5 Top-Ranked Quality Stocks

2018-06-21 zacks
Now that trade tension between the United States and China have taken the Wall Street in its grip, exposure to quality picks has become necessary. There are various ratios that can help you find great stocks. Return on equity is one of them. (9-0)

TripAdvisor Boosts Online Meal Service With delivery.com

2018-06-21 zacks
TripAdvisor, Inc. (TRIP - Free Report) users have some good news in the offing. The company has added another food-delivery service, delivery.com, to its offerings. (23-0)

CUSIP: 120076104